866-997-4948(US-Canada Toll Free)

Global Market Study on Antibody Library Technologies: Phage Display Segment by Technology to Register a CAGR of 5.0% During 2016-2024

Published By :

Persistence Market Research

Published Date : May 2017

Category :

Healthcare

No. of Pages : 157

Collaborations and cross-licensing are the key strategies adopted by a majority of players in the global antibody library technologies market. In a new publication titled Antibody Library Technologies Market: Global Industry Analysis and Forecast, 2016-2024, the analysts at Persistence Market Research have observed that antibodies being a most successful biotechnology drug class, pharmaceutical companies are striving to add antibodies to their pipeline in order to alleviate patent cliff. While studying the various market segments the expert team of analysts have noted that North America represents the most lucrative regional market, followed by Europe and APAC. Another key observation is that despite phage display being the fastest growing technology, yeast display system is becoming a choice of technology due to the improved quality of MAB obtained through it. This report provides useful information regarding transitions in the business value proposition of key players. For instance, MorphoSys AG has set a goal to build the most valuable biopharmaceutical pipeline in the biotech industry and in line with this, the company is shifting its focus from technology licensing to drug development.

Major deals in the global antibody library technologies market

  • In August 2016, Italy-based biotechnology company Philogen entered into a collaboration agreement with Janssen Biotech Inc. - a Johnson & Johnson Company
  • In April 2016, Adimab LLC announced the signing of a collaboration agreement with Takeda Pharmaceutical Company Ltd.
  • In January 2016, Adimab LLC licensed its proprietary antibody libraries to Merck KGaA, under which Merck will internalize the Adimab technology and apply it broadly across its R&D programs

Why are Antibody Libraries not widely perceived as research reagents?

Although the antibodies selected by in vitro method are very powerful, the technology is not widely perceived as a valuable research reagent. The primary reason is a patent situation, which limits the use of this technology to high margin therapeutic markets. In contrast, classical hybridoma technology was never patented and thus achieved widespread acceptance in academics as well as for commercial purposes within a short period of time. However, some of the phage display patents are about to expire in the next few years while some have already expired, which may result in wide acceptance of the new technology. This technology is largely unnoticed by the research community due to the dominance of traditional hybridoma technology in most of the markets. For instance, some of the commercially available monoclonal antibodies are actually obtained by phage display screening but are reformatted to resemble murine antibodies.

Market Segmentation

By Technology

  • Phage Display
  • Ribosome Display
  • Yeast Display
  • Mammalian Cell Display

By Application

  • Drug Discovery
  • Basic Research
  • Others

By End User

  • Biopharmaceutical Companies
  • Academic & Research Institutes

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Research Methodology

The analysts have developed questionnaires for each node in the value chain to extract the required market information through primary research interviews. Persistence Market Research has adopted systematic exhaustive secondary research to analyze the required data points to arrive at the overall market numbers. Data is validated using the triangulation method, wherein secondary, primary and Persistence Market Research analysis contribute to the final data. Yearly change in inflation rate has not been factored in while forecasting market numbers. Bottom-up approach has been used to assess market numbers for each product category, while top-down approach has been used to counter-validate the reached numbers. Indicators such as R&D expenditure, research funding from government and non-profit organizations etc. have been considered to arrive at the indicated market numbers. Historical consumption trend has been analyzed to track market data. Secondary research includes various company websites, annual reports, white papers and financial reports, while paid publications for research include Factiva, GBI, Genios and Meltwaters.

Company Profiles

  • MorphoSys AG
  • Dyax Corp.
  • Abzena Plc.
  • XOMA Corporation
  • AvantGen Inc.
  • Creative-biolabs
  • AbCheck s.r.o.
  • Philogen S.p.A.
  • Adimab LLC
  • Invenra Inc.
  • AnaptysBio, Inc.
  • Abwiz Bio Inc.
  • Abgent Inc. (WuXi AppTec company)
  • Vaccinex Inc.
  • AxioMx Inc.
  • Others

1. Executive Summary

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy

3. Global Antibody Library Application Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity

4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Forecast Factors - Relevance and Impact
4.6.Recent Developments In Antibody Library Technologies Market
4.7.Major Deals in Global Antibody Library Technology Market
4.8. Technology Assessment
4.9. Antibody Libraries- Why Not Widely Perceived as Research Reagent?

5. Global Antibody Library Application Market Analysis and Forecasts, By Technology
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Technology
5.3. Y-o-Y Growth Projections By Technology
5.4. Market Value Forecast By Application, 2016-2024
5.4.1. Phage Display
5.4.2. Ribosome Display
5.4.3. Yeast Display
5.4.4. Mammalian Cell Display
5.5. Market Attractiveness By Technology

6. Global Antibody Library Application Market Analysis and Forecasts, By End User
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By End User
6.3. Y-o-Y Growth Projections By End User
6.4. Market Value Forecast By End User, 2016-2024
6.4.1. Biopharmaceutical Companies
6.4.2. Academic & Research Institutes
6.5. Market Attractiveness By End User

7. Global Antibody Library Application Market Analysis and Forecasts, By Application
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Application
7.3. Y-o-Y Growth Projections By Application
7.4. Market Value Forecast By Application, 2016-2024
7.4.1. Drug Discovery
7.4.2. Diagnostics
7.4.3. Basic Research
7.5. Market Attractiveness By Application

8. Global Antibody Library Application Market Analysis and Forecasts, By Region
8.1. Basis Point Share (BPS) Analysis By Region
8.2. Y-o-Y Growth Projections By Region
8.3. Market Value Forecast By Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. APEJ
8.3.5. MEA
8.4. Market Attractiveness By Region

9. North America Antibody Library Application Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Technology
9.1.2. Y-o-Y Growth Projections By Technology
9.2. Market Value Forecast By Application, 2016-2024
9.2.1. Phage Display
9.2.2. Ribosome Display
9.2.3. Yeast Display
9.2.4. Mammalian Cell Display
9.3. Market Value Forecast By End User, 2016-2024
9.3.1. Biopharmaceutical Companies
9.3.2. Academic & Research Institutes
9.4. Market Value Forecast By Application, 2016-2024
9.4.1. Drug Discovery
9.4.2. Diagnostics
9.4.3. Basic Research
9.5. Market Attractiveness Analysis
9.5.1. By Technology
9.5.2. By End User
9.5.3. By Application

10. Latin America Antibody Library Application Market Analysis and Forecast
10.1.Introduction
10.1.1. Basis Point Share (BPS) Analysis By Technology
10.1.2. Y-o-Y Growth Projections By Technology
10.2.Market Value Forecast By Technology, 2016-2024
10.2.1. Phage Display
10.2.2. Ribosome Display
10.2.3. Yeast Display
10.2.4. Mammalian Cell Display
10.3.Market Value Forecast By End User, 2016-2024
10.3.1. Biopharmaceutical Companies
10.3.2. Academic & Research Institutes
10.4.Market Value Forecast By Application, 2016-2024
10.4.1. Drug Discovery
10.4.2. Diagnostics
10.4.3. Basic Research
10.5.Market Attractiveness Analysis
10.5.1. By Technology
10.5.2. By End User
10.5.3. By Application

11. Europe Antibody Library Application Market Analysis and Forecast
11.1.Introduction
11.1.1. Basis Point Share (BPS) Analysis By Technology
11.1.2. Y-o-Y Growth Projections By Technology
11.2.Market Value Forecast By Technology, 2016-2024
11.2.1. Phage Display
11.2.2. Ribosome Display
11.2.3. Yeast Display
11.2.4. Mammalian Cell Display
11.3.Market Value Forecast By End User, 2016-2024
11.3.1. Biopharmaceutical Companies
11.3.2. Academic & Research Institutes
11.4.Market Value Forecast By Application, 2016-2024
11.4.1. Drug Discovery
11.4.2. Diagnostics
11.4.3. Basic Research
11.5.Market Attractiveness Analysis
11.5.1. By Technology
11.5.2. By End User
11.5.3. By Application

12. APEJ Antibody Library Application Market Analysis and Forecast
12.1.Introduction
12.1.1. Basis Point Share (BPS) Analysis By Technology
12.1.2. Y-o-Y Growth Projections By Technology
12.2.Market Value Forecast By Technology, 2016-2024
12.2.1. Phage Display
12.2.2. Ribosome Display
12.2.3. Yeast Display
12.2.4. Mammalian Cell Display
12.3.Market Value Forecast By End User, 2016-2024
12.3.1. Biopharmaceutical Companies
12.3.2. Academic & Research Institutes
12.4.Market Value Forecast By Application, 2016-2024
12.4.1. Drug Discovery
12.4.2. Diagnostics
12.4.3. Basic Research
12.5.Market Attractiveness Analysis
12.5.1. By Technology
12.5.2. By End User
12.5.3. By Application

13. MEA Antibody Library Application Market Analysis and Forecast
13.1.Introduction
13.1.1. Basis Point Share (BPS) Analysis By Technology
13.1.2. Y-o-Y Growth Projections By Technology
13.2.Market Value Forecast By Technology, 2016-2024
13.2.1. Phage Display
13.2.2. Ribosome Display
13.2.3. Yeast Display
13.2.4. Mammalian Cell Display
13.3.Market Value Forecast By End User, 2016-2024
13.3.1. Biopharmaceutical Companies
13.3.2. Academic & Research Institutes
13.4.Market Value Forecast By Application, 2016-2024
13.4.1. Drug Discovery
13.4.2. Diagnostics
13.4.3. Basic Research
13.5.Market Attractiveness Analysis
13.5.1. By Technology
13.5.2. By End User
13.5.3. By Application

14. Competition Landscape
14.1. Competition Dashboard
14.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
14.2.1. MorphoSys AG
14.2.2. Dyax Corp.
14.2.3. Abzena Plc.
14.2.4. XOMA Corporation
14.2.5. AvantGen Inc.
14.2.6. Creative-biolabs
14.2.7. AbCheck s.r.o.
14.2.8. Philogen S.p.A.
14.2.9. Adimab LLC
14.2.10. Invenra Inc.
14.2.11. AnaptysBio, Inc.
14.2.12. Abwiz Bio Inc.
14.2.13. Abgent Inc. (WuXi AppTec company)
14.2.14. Vaccinex Inc.
14.2.15. AxioMx Inc.

15. Assumptions and Acronyms Used

16. Research Methodology

List of Table

Table 01: Global Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Technology, 2015-2024
Table 02: Global Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Application, 2015-2024
Table 03: Global Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By End User, 2015-2024
Table 04: Global Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Region, 2015-2024
Table 05: North America Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Technology, 2015-2024
Table 06: North America Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Application, 2015-2024
Table 07: North America antibody library technologies market Value (US$ Mn) Analysis and Forecast By End User, 2015-2024
Table 08: Latin America Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Technology, 2015-2024
Table 09: Latin America Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Application, 2015-2024
Table 10: Latin America antibody library technologies market Value (US$ Mn) Analysis and Forecast By End User, 2015-2024
Table 11: Europe Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Technology, 2015-2024
Table 12: Europe Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Application, 2015-2024
Table 13: Europe antibody library technologies market Value (US$ Mn) Analysis and Forecast By End User, 2015-2024
Table 14: APAC Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Technology, 2015-2024
Table 15: APAC Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Application, 2015-2024
Table 16: APAC antibody library technologies market Value (US$ Mn) Analysis and Forecast By End User, 2015-2024
Table 17: MEA Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Technology, 2015-2024
Table 18: MEA Antibody Library Technologies Market Value (US$ Mn) Analysis and Forecast By Application, 2015-2024
Table 19: MEA antibody library technologies market Value (US$ Mn) Analysis and Forecast By End User, 2015-2024

List of Chart

Figure 01: Global Antibody Library Technologies Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
Figure 02: Global Antibody Library Technologies Market Absolute $ Opportunity, 2016-2024
Figure 03: Global Antibody Library Technologies Market Value Share Analysis (%) By Technology, 2016 & 2024
Figure 04: Global Antibody Library Technologies Market Y-o-Y growth (%) By Technology, 2016-2024
Figure 05: Global antibody library technologies market Absolute $ Opportunity By Phage Display Technology, 2016-2024
Figure 06: Global antibody library technologies market Absolute $ Opportunity By Ribosome Display Technology, 2016-2024
Figure 07: Global antibody library technologies market Absolute $ Opportunity By Yeast Display Technology, 2016-2024
Figure 08: Global antibody library technologies market Absolute $ Opportunity By Mammalian Cell Display Technology, 2016-2024
Figure 09: Global antibody library technologies market Attractiveness Analysis By Technology, 2016-2024
Figure 10: Global Antibody Library Technologies Market Value Share Analysis (%) By Application, 2016 & 2024
Figure 11: Global Antibody Library Technologies Market Y-o-Y growth (%) By Application, 2016-2024
Figure 12: Global Antibody Library Technologies Market Absolute $ Opportunity By Drug Discovery Application, 2016-2024
Figure 13: Global antibody library technologies market Absolute $ Opportunity By Diagnostic Application, 2016-2024
Figure 14: Global antibody library technologies market Absolute $ Opportunity By Basic Research Application, 2016-2024
Figure 15: Global antibody library technologies market Attractiveness Analysis By Application, 2016-2024
Figure 16: Global Antibody Library Technologies Market Value Share Analysis (%) By End User, 2016 & 2024
Figure 17: Global Antibody Library Technologies Market Y-o-Y growth (%) By End User, 2016-2024
Figure 18: Global Antibody Library Technologies Market Absolute $ Opportunity By Biopharmaceutical Companies, 2016-2024
Figure 19: Global Antibody Library Technologies Market Absolute $ Opportunity By Academic and Research Institutes, 2016-2024
Figure 20: Global Antibody Library Technologies Market Attractiveness Analysis By End User, 2016-2024
Figure 21: Global Antibody Library Technologies Market Value Share Analysis (%) By Region, 2016 & 2024
Figure 22: Global Antibody Library Technologies Market Y-o-Y growth (%) By Region, 2016-2024
Figure 23: North America Antibody Library Technologies Market Absolute $ Opportunity, 2016-2024
Figure 24: Latin America Antibody Library Technologies Market Absolute $ Opportunity, 2016-2024
Figure 25: Europe Antibody Library Technologies Market Absolute $ Opportunity, 2016-2024
Figure 26: APAC Antibody Library Technologies Market Absolute $ Opportunity, 2016-2024
Figure 27: MEA Antibody Library Technologies Market Absolute $ Opportunity, 2016-2024
Figure 28: Global Antibody Library Technologies Market Attractiveness Analysis By Region, 2016-2024
Figure 29: North America Antibody Library Technologies Market Value Share Analysis (%) By Technology, 2016 & 2024
Figure 30: North America Antibody Library Technologies Market Y-o-Y growth (%) By Technology, 2016-2024
Figure 31: North America antibody library technologies market Attractiveness Analysis By Technology, 2016-2024
Figure 32: North America antibody library technologies market Attractiveness Analysis By Application, 2016-2024
Figure 33: North America antibody library technologies market Attractiveness Analysis By End User, 2016-2024
Figure 34: Latin America Antibody Library Technologies Market Value Share Analysis (%) By Technology, 2016 & 2024
Figure 35: Latin America Antibody Library Technologies Market Y-o-Y growth (%) By Technology, 2016-2024
Figure 36: Latin America antibody library technologies market Attractiveness Analysis By Technology, 2016-2024
Figure 37: Latin America antibody library technologies market Attractiveness Analysis By Application, 2016-2024
Figure 38: Latin America antibody library technologies market Attractiveness Analysis By End User, 2016-2024
Figure 39: Europe Antibody Library Technologies Market Value Share Analysis (%) By Technology, 2016 & 2024
Figure 40: Europe Antibody Library Technologies Market Y-o-Y growth (%) By Technology, 2016-2024
Figure 41: Europe antibody library technologies market Attractiveness Analysis By Technology, 2016-2024
Figure 42: Europe antibody library technologies market Attractiveness Analysis By Application, 2016-2024
Figure 43: Europe antibody library technologies market Attractiveness Analysis By End User, 2016-2024
Figure 44: APAC Antibody Library Technologies Market Value Share Analysis (%) By Technology, 2016 & 2024
Figure 45: APAC Antibody Library Technologies Market Y-o-Y growth (%) By Technology, 2016-2024
Figure 46: APAC antibody library technologies market Attractiveness Analysis By Technology, 2016-2024
Figure 47: APAC antibody library technologies market Attractiveness Analysis By Application, 2016-2024
Figure 48: APAC antibody library technologies market Attractiveness Analysis By End User, 2016-2024
Figure 49: MEA Antibody Library Technologies Market Value Share Analysis (%) By Technology, 2016 & 2024
Figure 50: MEA Antibody Library Technologies Market Y-o-Y growth (%) By Technology, 2016-2024
Figure 51: MEA antibody library technologies market Attractiveness Analysis By Technology, 2016-2024
Figure 52: MEA antibody library technologies market Attractiveness Analysis By Application, 2016-2024
Figure 53: MEA antibody library technologies market Attractiveness Analysis By End User, 2016-2024

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *